Vor Historical Balance Sheet
VOR Stock | USD 1.08 0.03 2.70% |
Trend analysis of Vor Biopharma balance sheet accounts such as Total Assets of 151.6 M, Short Long Term Debt Total of 25.4 M, Other Current Liabilities of 13.2 M or Total Current Liabilities of 10.8 M provides information on Vor Biopharma's total assets, liabilities, and equity, which is the actual value of Vor Biopharma to its prevalent stockholders. By breaking down trends over time using Vor Biopharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Vor Biopharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vor Biopharma is a good buy for the upcoming year.
Vor |
About Vor Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Vor Biopharma at a specified time, usually calculated after every quarter, six months, or one year. Vor Biopharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Vor Biopharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Vor currently owns. An asset can also be divided into two categories, current and non-current.
Vor Biopharma Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Vor Biopharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vor Biopharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Vor Biopharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Vor Biopharma are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Vor Biopharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Vor Biopharma current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vor Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.At this time, Vor Biopharma's Other Stockholder Equity is relatively stable compared to the past year. As of 03/02/2025, Property Plant And Equipment Gross is likely to grow to about 70.3 M, while Short and Long Term Debt Total is likely to drop slightly above 25.4 M.
2022 | 2023 | 2024 | 2025 (projected) | Short and Long Term Debt Total | 38.9M | 35.7M | 41.0M | 25.4M | Total Assets | 299.4M | 198.1M | 227.8M | 151.6M |
Vor Biopharma balance sheet Correlations
Click cells to compare fundamentals
Vor Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vor Biopharma balance sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 75.9M | 242.6M | 299.4M | 198.1M | 227.8M | 151.6M | |
Other Current Liab | 6.1M | 4.9M | 4.8M | 10.9M | 12.6M | 13.2M | |
Total Current Liabilities | 10.2M | 10.2M | 13.1M | 15.6M | 17.9M | 10.8M | |
Total Stockholder Equity | 48.3M | 216.3M | 250.6M | 150.7M | 173.3M | 122.2M | |
Net Tangible Assets | (17.4M) | (59.1M) | 216.3M | 250.6M | 288.2M | 302.6M | |
Property Plant And Equipment Net | 21.8M | 22.5M | 57.1M | 50.1M | 57.6M | 60.5M | |
Net Debt | (30.2M) | (101.8M) | (18.8M) | 4.3M | 3.9M | 4.1M | |
Retained Earnings | (61.2M) | (130.1M) | (222.2M) | (340.1M) | (306.1M) | (290.8M) | |
Accounts Payable | 2.4M | 1.5M | 1.8M | 815K | 937.3K | 1.3M | |
Cash | 48.5M | 119.8M | 57.7M | 31.4M | 36.1M | 48.5M | |
Non Current Assets Total | 26.8M | 28.2M | 62.4M | 57.3M | 65.9M | 69.2M | |
Cash And Short Term Investments | 48.5M | 207.5M | 230.2M | 137.2M | 157.8M | 115.7M | |
Common Stock Shares Outstanding | 37.1M | 37.2M | 39.6M | 67.2M | 77.3M | 41.0M | |
Liabilities And Stockholders Equity | 75.9M | 242.6M | 299.4M | 198.1M | 227.8M | 151.6M | |
Non Current Liabilities Total | 17.4M | 16.2M | 35.6M | 31.8M | 36.6M | 18.7M | |
Other Current Assets | 567K | 6.9M | 6.7M | 3.6M | 4.2M | 3.3M | |
Other Stockholder Equity | 2.2M | 346.4M | 473.6M | 490.9M | 564.5M | 592.7M | |
Total Liab | 27.6M | 26.3M | 48.8M | 47.4M | 54.5M | 29.3M | |
Net Invested Capital | (59.1M) | 216.3M | 250.6M | 150.7M | 173.3M | 98.8M | |
Property Plant And Equipment Gross | 21.8M | 24.6M | 61.7M | 58.2M | 66.9M | 70.3M | |
Total Current Assets | 49.1M | 214.4M | 237.0M | 140.8M | 161.9M | 119.1M | |
Capital Stock | 25.1M | 107.3M | 4K | 7K | 6.3K | 6.0K | |
Net Working Capital | 38.9M | 204.2M | 223.8M | 125.2M | 144.0M | 108.3M | |
Property Plant Equipment | 728K | 21.8M | 6.9M | 12.6M | 14.5M | 9.3M | |
Non Currrent Assets Other | 3.4M | 3.3M | 2.9M | 7.2M | 8.3M | 8.7M |
Additional Tools for Vor Stock Analysis
When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.